Literature DB >> 1316864

Characterization of the mcrBC region of Escherichia coli K-12 wild-type and mutant strains.

T Krüger1, C Grund, C Wild, M Noyer-Weidner.   

Abstract

We have carried out an analysis of the Escherichia coli K-12 mcrBC locus in order to (1) elucidate its genetic organization, (2) to identify the proteins encoded by this region, and (3) to characterize their involvement in the restriction of DNA containing methylated cytosine residues. In vitro expression of recombinant plasmids carrying all or portions of the mcrBC region revealed that the mcrB and mcrC genes are organized as an operon. The mcrBC operon specifies five proteins, as evident from parallel in vitro and in in vivo expression studies. Three proteins of 53, 35 and 34 kDa originate from mcrB expression, while two proteins of 37 and 16 kDa arise from mcrC expression. Products of both the mcrB and mcrC genes are required to restrict the methylated substrate DNA used in this study. We also determined the nature of mutant mcrBC loci in comparison to the E. coli K-12 wild-type mcrBC locus. A major goal of these studies was to clarify the nature of the mcrB-1 mutation, which is carried by some strains employed in previous analyses of the E. coli K-12 McrBC system. Based on our analyses the mutant strains investigated could be divided into different complementation groups. The mcrB-1 mutation is a nonsense or frameshift mutation located within mcrB. It causes premature termination of mcrB gene product synthesis and reduces the level of mcrC gene expression. This finding helps to understand an existing conflict in the literature. We also describe temperature-sensitive McrA activity in some of the strains analysed and its relationship to the previously defined differences in the tolerance levels of E. coli K-12 mcrBC mutants to cytosine methylation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316864     DOI: 10.1016/0378-1119(92)90700-y

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  M.(phi)BssHII, a novel cytosine-C5-DNA-methyltransferase with target-recognizing domains at separated locations of the enzyme.

Authors:  S Sethmann; P Ceglowski; J Willert; R Iwanicka-Nowicka; T A Trautner; J Walter
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  Nucleoside triphosphate-dependent restriction enzymes.

Authors:  D T Dryden; N E Murray; D N Rao
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

3.  The McrBC restriction endonuclease assembles into a ring structure in the presence of G nucleotides.

Authors:  D Panne; S A Müller; S Wirtz; A Engel; T A Bickle
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

4.  McrBs, a modulator peptide for McrBC activity.

Authors:  D Panne; E A Raleigh; T A Bickle
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

5.  Exact size and organization of DNA target-recognizing domains of multispecific DNA-(cytosine-C5)-methyltransferases.

Authors:  T A Trautner; B Pawlek; B Behrens; J Willert
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

Review 6.  Linkage map of Escherichia coli K-12, edition 10: the traditional map.

Authors:  M K Berlyn
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

7.  Evidence of participation of McrB(S) in McrBC restriction in Escherichia coli K-12.

Authors:  T P Beary; H D Braymer; E C Achberger
Journal:  J Bacteriol       Date:  1997-12       Impact factor: 3.490

Review 8.  Biology of DNA restriction.

Authors:  T A Bickle; D H Krüger
Journal:  Microbiol Rev       Date:  1993-06

Review 9.  Conflicts targeting epigenetic systems and their resolution by cell death: novel concepts for methyl-specific and other restriction systems.

Authors:  Ken Ishikawa; Eri Fukuda; Ichizo Kobayashi
Journal:  DNA Res       Date:  2010-11-08       Impact factor: 4.458

Review 10.  Functions of the gene products of Escherichia coli.

Authors:  M Riley
Journal:  Microbiol Rev       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.